Bone Loss

Also known as: Osteopenia / Osteopaenia

DrugDrug NameDrug Description
DB06643DenosumabA RANK ligand (RANKL) inhibitor used for the management of osteoporosis in patients at high risk for bone fractures.
DrugDrug NamePhaseStatusCount
DB06643Denosumab0Active Not Recruiting1
DB06643Denosumab0Completed1
DB06285Teriparatide1Completed1
DB00878Chlorhexidine1 / 2Not Yet Recruiting1
DB00399Zoledronic acid1 / 2Not Yet Recruiting1
DB00630Alendronic acid2Completed1
DB00136Calcitriol2Active Not Recruiting1
DB01373Calcium2Completed1
DB00169Cholecalciferol2Active Not Recruiting1
DB06202Lasofoxifene2Completed1
DB00227Lovastatin2Recruiting1
DB06285Teriparatide2Completed2
DB11094Vitamin D2Completed1
DB00399Zoledronic acid2Active Not Recruiting1
DB00399Zoledronic acid2Completed2
DB00399Zoledronic acid2Terminated1
DB00783Estradiol3Withdrawn1
DB01006Letrozole3Completed1
DB00396Progesterone3Withdrawn1
DB00399Zoledronic acid3Completed1
DB11799Bictegravir4Recruiting1
DB06643Denosumab4Recruiting1
DB00879Emtricitabine4Recruiting1
DB00282Pamidronic acid4Completed1
DB00884Risedronic acid4Active Not Recruiting1
DB00884Risedronic acid4Completed3
DB09299Tenofovir alafenamide4Recruiting1
DB06285Teriparatide4Completed1
DB00399Zoledronic acid4Recruiting1
DB00399Zoledronic acidNot AvailableCompleted1
DB00399Zoledronic acidNot AvailableRecruiting1